Atlas Trials

Desipramine for Improving Cellular Signaling and Decreasing Symptoms of Major Depression

Clinical trial NCT00320632 · COMPLETED

Trial details

NCT number
NCT00320632
Sponsor
Harvard Medical School (HMS and HSDM)
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Depression
Start date
1990-08-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.